New Genetics and Society

Papers
(The median citation count of New Genetics and Society is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Governance through scientism: Taiwan Biobank and public controversy16
Human heritable genome editing and its governance: views of scientists and governance professionals12
Donors: curious connections in donor conception Donors: curious connections in donor conception , by P. Nordqvist and L. Gilman, Bingley, Emerald Group Publishing, 2022,10
Editorial: themed issue: understanding the technical and social landscape of gene editing9
The unexpected and unanticipated announcement of the “world’s first” gene edited babies: breaching, repairing and strengthening community boundaries9
Capitalization and the production of value at the nexus of academia and industry: the case of a microbiome startup9
The matrix of stem cell research: an approach to rethinking science in society9
Public concerns about direct-to-consumer DNA test kits: the evidence from survey and social media data7
Safe and purposeful genome editing under harmonized regulation for responsible use: views of research experts6
The omics of our lives: practices and policies of direct-to-consumer epigenetic and microbiomic testing companies5
Consensus too soon: judges’ and lawyers’ views on genetic information use5
Healthcare activism: markets, morals, and the collective good Healthcare activism: markets, morals, and the collective good , edited by Susi Geiger, Oxford, Oxford Unive5
Exploring “quality” in cord blood transfusion: uncertainties, bionetworks, and collaborations4
Laboring bodies and the quantified self4
“It’s personalized, but it’s still bucket based”: the promise of personalized medicine vs. the reality of genomic risk stratification in a breast cancer screening trial4
Freezing fertility: oocyte cryopreservation and the gender politics of aging3
Commoning contingent resources: constructing an Australian stem cell registry3
“We are all cousins.” Belgian ancestry and genomic testing in a close-knit community in Northeastern Wisconsin3
Many thanks for New Genetics and Society reviewers2
Toxic disruptions: polycystic ovary syndrome in urban India2
The color of creatorship: intellectual property, race, and the making of Americans2
Building the airplane while flying it: tracking the transformation of novel sequencing practices into clinical services2
Recoding the gift relationship: views on introducing genomic testing to blood donation2
Siloed discourses: a year-long study of twitter engagement on the use of CRISPR in food and agriculture2
Reinterpreting “genetic identity” in the regulatory and ethical context of heritable genome editing2
Goffman against DNA: genetic stigma and the use of genetic ancestry tests by white nationalists2
Acid Revival: The psychedelic renaissance and the quest for medical legitimacy1
Mitochondrial replacement in the English-language print media: continuity and change in metaphors and social representations1
Bio-imperialism. Disease, terror and the construction of national fragility1
Expanding the notion of “benefit”: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns1
Constructing maternal responsibility: narratives of “motherly love” and maternal blame in epigenetics research1
The challenge of recruiting diverse populations into health research: an embedded social science perspective1
“I am happy to be alive, but I prefer to have children without my chronic disease”: chronically ill persons’ views on reproduction and genetic testing for their own condition1
“It didn’t mean anything” – moving within a landscape of knowledge to interpret genetics and genetic test results within familial cancer concerns1
How we get Mendel wrong, and why it matters: challenging the narrative of Mendelian genetics1
The Muslim genome: postcolonial nation-building through genomics in Pakistan0
The platforming of human embryo editing: prospecting “disease free” futures0
Ancestral genomics: African American health in the age of precision medicine0
“Idealists and capitalists”: ownership attitudes and preferences in genomic citizen science0
“Donating with eyes shut”: attitudes regarding DNA donation to a large-scale biobank in Israel0
Genetic subjectivities of prospective fathers: men’s attitudes toward epigenetics0
A place for science and technology studies. Observation, collaboration and intervention0
Genetics and the Politics of Security: a social science perspective0
“If relatives inherited the gene, they should inherit the data.” Bringing the family into the room where bioethics happens0
Correction0
In Memoriam of Andrew Webster0
The pathos of precision0
Making sense: markets from stories in new breast cancer therapeutics0
Intrinsic responsible innovation in a synthetic biology research project0
“Law at the frontiers of biomedicine”0
A History of Genomics Across Species, Communities and Projects0
Use of tissue and health data: attachments and detachments among an enabling public0
“Doing genetic literacy”: a discourse-oriented approach to literacy in genetic contexts0
Gene drive communication: exploring experts’ lived experience of metaphor use0
Applying a risk governance approach to examine how professionals perceive the benefits and risks of clinical genomics in Australian healthcare0
“Doing Good” in U.S. Cancer Genomics? Valuation practices across the boundaries of research and care in rural community oncology0
Ancestry reimagined: dismantling the myth of genetic ethnicities0
Being Human during COVID-19 Being Human during COVID-19 , edited by Paul Martin, Stevienna de Saille, Kirsty Liddiard and Warren Pearce, Bristol University Press, 2022, 0
Environmental sustainability and biobanking: a pilot study of the field0
The rise of the biocyborg: synthetic biology, artificial chimerism and human enhancement0
Embodiment and everyday cyborgs Embodiment and everyday cyborgs , by Gill Haddow, Manchester, Manchester University Press, 2021, 216 pp., $36.95 (hardback), ISBN-13: 9780
Capitalizing a cure: how finance controls the price and value of medicines0
Conviction: the making and unmaking of the violent brain0
Strategies on personalized medicine and the power of the imagined public0
Navigating narratives of genetic categorization at the frayed edges of identity0
The new stage of public engagement with science in the digital media environment: citizen science communicators in the discussion of GMOs on Zhihu0
Thinking the unthinkable: how did human germline genome editing become ethically acceptable?0
Are we ready for the genomic era? Insights from judges and lawyers0
Promising precision medicine: how patients, clinicians and caregivers work to realize the potential of genomics-informed cancer care0
The salience of genomic information to reproductive autonomy: Australian healthcare professionals’ views on a changing prenatal testing landscape0
0.049599885940552